Algorithmiq is a Finnish startup founded in 2020 with the slogan "We develop advanced quantum algorithms to solve complex problems in life sciences." The company specializes in developing advanced algorithms to tackle complex issues in the biotechnology, life sciences, quantum, and marketing industries. Algorithmiq's mission is to revolutionize life sciences by harnessing the potential of quantum computing to solve currently inaccessible problems. The company combines its expertise in quantum information, complex systems, and computational physics to develop algorithms that run on near-term quantum devices, aiding in the discovery of new drugs and the development of innovative materials. Algorithmiq recently secured a significant €14.00M Series A investment on 27 June 2023 from notable investors including Presidio Ventures, Tesi, Thames Trust, Inventure, and the European Investment Bank. This latest investment highlights the confidence of these prominent investors in the potential of Algorithmiq's pioneering work at the intersection of quantum computing and life sciences.